364 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
ABT Abbott Laboratories $67.67 $118.71B N/A
Article Searches
Why Straight Path Communications, Alere, and MoneyGram International Jumped Today https://www.fool.com/investing/2017/04/17/why-straight-path-communications-alere-and-moneygr.aspx?source=iedfolrf0000001 Apr 17, 2017 - These stocks helped lead the market higher. Find out why.
Alere Inc. Shares Surge After Renewed Commitment From Abbott Laboratories https://www.fool.com/investing/2017/04/17/alere-inc-shares-surge-after-renewed-commitment-fr.aspx?source=iedfolrf0000001 Apr 17, 2017 - Despite a lower price, Abbott's agreement to acquire Alere Inc. gives shareholders a reason to cheer.
Cyber Insurance Becomes a Must for More Manufacturers https://www.wsj.com/articles/cyber-insurance-becomes-a-must-for-more-manufacturers-1492426801?mod=rss_Technology Apr 17, 2017 - The recent exposure of cybersecurity threats to some Abbott Laboratories implanted heart devices helps explain why manufacturers have been rushing to make sure they are protected by cyber insurance.
Company News for April 17, 2017 http://www.zacks.com/stock/news/256552/company-news-for-april-17-2017?cid=CS-ZC--256552 Apr 17, 2017 - Companies in the News are: ABT,UAL,GS,PIR
Abbott Laboratories Agrees to Acquire Alere at Lower Price http://www.zacks.com/stock/news/256533/abbott-laboratories-agrees-to-acquire-alere-at-lower-price?cid=CS-ZC-FT-256533 Apr 17, 2017 - Abbott has agreed to pay $51 per common share to acquire Alere, a reduction from earlier deal of $56 per common share upon the completion of the transaction.
Abbott, Alere Advance Merger With Reduced Price https://www.wsj.com/articles/abbott-alere-advance-contentious-merger-with-reduced-price-1492168496?mod=pls_whats_news_us_business_f Apr 14, 2017 - Abbott Laboratories and Alere Inc. reached an agreement to move forward with their contentious merger, with Abbott—which had sought to wriggle out of the deal—paying a lower price.
Will Abbott Lab (ABT) Surprise Estimates in Q1 Earnings? http://www.zacks.com/stock/news/256186/will-abbott-lab-abt-surprise-estimates-in-q1-earnings?cid=CS-ZC-FT-256186 Apr 12, 2017 - Abbott Laboratories (ABT) is scheduled to report first-quarter 2017 results before the opening bell on Apr 19.
Top Research Reports for Today: DIS, TXN, LMT http://www.zacks.com/research-daily/108307/top-research-reports-for-today-dis-txn-lmt?cid=CS-ZC-FT-108307 Mar 31, 2017 - Top Research Reports for Today: DIS, TXN, LMT
Abbott's St Jude Buyout to Boost Business, Risks Remain http://www.zacks.com/stock/news/254856/abbotts-st-jude-buyout-to-boost-business-risks-remain?cid=CS-ZC-FT-254856 Mar 31, 2017 - On Mar 31, we updated our research report on medical device major, Abbott Laboratories (ABT).
MedTech Long-Term Prospects Impress: Which Stocks to Buy? http://www.zacks.com/commentary/107282/medtech-long-term-prospects-impress-which-stocks-to-buy?cid=CS-ZC--107282 Mar 22, 2017 - MedTech Long-Term Prospects Impress: Which Stocks to Buy?

Pages: 1...28293031323334353637

<<<Page 33>